Hamilton Lane Inc. (NASDAQ:HLNE) Receives Consensus Rating of "Moderate Buy" from Analysts

Key Points

• Consensus "Moderate Buy": Ten analysts rate Hamilton Lane with a consensus of Moderate Buy (six buys, four holds) and an average 12‑month price target of about $155.38.
• Analyst views have diverged recently with several firms trimming targets — recent published targets span roughly $118–$171, while JPMorgan upgraded to overweight and Oppenheimer maintains an outperform stance.
• Fundamentals remain solid: Hamilton Lane beat the quarter (EPS $1.55 vs $1.28, revenue $198.6M), shows strong profitability (ROE ~27.8%, net margin ~30.6%), and trades around $91.12, well below analyst targets and its 52‑week high.

Hamilton Lane Inc. (NASDAQ:HLNE - Get Free Report) has been given a consensus rating of "Moderate Buy" by the ten ratings firms that are presently covering the company, Marketbeat Ratings reports. Four analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $155.3750.

Several analysts recently commented on the company. Oppenheimer decreased their target price on shares of Hamilton Lane from $230.00 to $171.00 and set an "outperform" rating for the company in a research report on Monday, April 13th. JPMorgan Chase & Co. upgraded shares of Hamilton Lane from a "neutral" rating to an "overweight" rating and set a $166.00 price target on the stock in a research report on Thursday, April 16th. Morgan Stanley dropped their price target on Hamilton Lane from $159.00 to $141.00 and set an "equal weight" rating on the stock in a report on Tuesday, April 21st. UBS Group cut their price objective on Hamilton Lane from $184.00 to $150.00 and set a "buy" rating for the company in a research report on Friday, February 20th. Finally, BMO Capital Markets reduced their price objective on Hamilton Lane from $148.00 to $118.00 and set an "outperform" rating for the company in a research note on Tuesday, March 24th.

Hamilton Lane Trading Down 1.6%

NASDAQ:HLNE opened at $91.12 on Tuesday. The company has a market cap of $5.08 billion, a PE ratio of 16.36 and a beta of 1.18. Hamilton Lane has a 52 week low of $86.47 and a 52 week high of $179.19. The business's 50 day moving average is $100.31 and its two-hundred day moving average is $120.63. The company has a quick ratio of 3.27, a current ratio of 3.27 and a debt-to-equity ratio of 0.21.

Hamilton Lane (NASDAQ:HLNE - Get Free Report) last released its quarterly earnings data on Tuesday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.28 by $0.27. The business had revenue of $198.59 million during the quarter, compared to analyst estimates of $195.36 million. Hamilton Lane had a return on equity of 27.82% and a net margin of 30.59%.The business's revenue for the quarter was up 18.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.25 EPS. On average, analysts predict that Hamilton Lane will post 6.2 EPS for the current year.

Institutional Trading of Hamilton Lane

Several hedge funds and other institutional investors have recently modified their holdings of the business. Royal Bank of Canada grew its holdings in shares of Hamilton Lane by 6.0% during the 1st quarter. Royal Bank of Canada now owns 52,466 shares of the company's stock valued at $7,800,000 after acquiring an additional 2,948 shares in the last quarter. Jones Financial Companies Lllp increased its holdings in shares of Hamilton Lane by 4,806.7% during the 1st quarter. Jones Financial Companies Lllp now owns 5,103 shares of the company's stock valued at $759,000 after acquiring an additional 4,999 shares during the last quarter. Geneos Wealth Management Inc. raised its position in shares of Hamilton Lane by 196.9% in the first quarter. Geneos Wealth Management Inc. now owns 383 shares of the company's stock valued at $57,000 after purchasing an additional 254 shares during the period. First Trust Advisors LP lifted its position in Hamilton Lane by 26.7% during the 2nd quarter. First Trust Advisors LP now owns 31,483 shares of the company's stock worth $4,474,000 after acquiring an additional 6,636 shares during the last quarter. Finally, Amundi increased its position in Hamilton Lane by 39,766.7% in the 2nd quarter. Amundi now owns 2,392 shares of the company's stock worth $347,000 after buying an additional 2,386 shares during the period. Institutional investors and hedge funds own 97.40% of the company's stock.

About Hamilton Lane

Hamilton Lane is a global private markets investment management firm specializing in the full spectrum of private equity and credit strategies. The company partners with institutional investors and wealth managers to design, implement and manage customized portfolios in primary fund investing, secondary market transactions and direct co-investment opportunities. By combining investment selection, portfolio construction and ongoing monitoring, Hamilton Lane seeks to optimize risk-adjusted returns across diverse private markets exposures.

Founded in 1991, Hamilton Lane has developed a track record of investment and advisory services in private markets.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.